Clinical and genomic analysis of a randomised phase II study evaluating anastrozole and fulvestrant in postmenopausal patients treated for large operable or locally advanced hormone-receptor-positive breast cancer
出版年份 2015 全文链接
标题
Clinical and genomic analysis of a randomised phase II study evaluating anastrozole and fulvestrant in postmenopausal patients treated for large operable or locally advanced hormone-receptor-positive breast cancer
作者
关键词
-
出版物
BRITISH JOURNAL OF CANCER
Volume 113, Issue 4, Pages 585-594
出版商
Springer Nature
发表日期
2015-07-15
DOI
10.1038/bjc.2015.247
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Neoadjuvant endocrine treatment in breast cancer: analysis of daily practice in large cancer center to facilitate decision making
- (2014) Marc Debled et al. AMERICAN JOURNAL OF SURGERY
- The therapeutic role of fulvestrant in the management of patients with hormone receptor-positive breast cancer
- (2014) Eva Ciruelos et al. BREAST
- Optimum duration of neoadjuvant letrozole to permit breast conserving surgery
- (2014) Robert Carpenter et al. BREAST CANCER RESEARCH AND TREATMENT
- Estrogen Receptor Mutations in Breast Cancer--New Focus on an Old Target
- (2014) C. V. Segal et al. CLINICAL CANCER RESEARCH
- Sox2 promotes tamoxifen resistance in breast cancer cells
- (2013) Marco Piva et al. EMBO Molecular Medicine
- Dose-dependent change in biomarkers during neoadjuvant endocrine therapy with fulvestrant: results from NEWEST, a randomized Phase II study
- (2012) Irene Kuter et al. BREAST CANCER RESEARCH AND TREATMENT
- Fulvestrant 500 mg versus anastrozole 1 mg for the first-line treatment of advanced breast cancer: follow-up analysis from the randomized ‘FIRST’ study
- (2012) John F. R. Robertson et al. BREAST CANCER RESEARCH AND TREATMENT
- Pathologic Changes in Breast Cancer After Anti-Estrogen Therapy
- (2012) Norasate Samarnthai et al. Breast Journal
- ELF5 Suppresses Estrogen Sensitivity and Underpins the Acquisition of Antiestrogen Resistance in Luminal Breast Cancer
- (2012) Maria Kalyuga et al. PLOS BIOLOGY
- Is the Ki-67 labelling index ready for clinical use?
- (2011) W. Jonat et al. ANNALS OF ONCOLOGY
- Correcting for cancer genome size and tumour cell content enables better estimation of copy number alterations from next-generation sequence data
- (2011) Arief Gusnanto et al. BIOINFORMATICS
- A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer
- (2011) Suleiman Massarweh et al. BREAST CANCER RESEARCH AND TREATMENT
- Nucleic Acid Quality Preservation by an Alcohol-based Fixative
- (2011) Isabelle Hostein et al. DIAGNOSTIC MOLECULAR PATHOLOGY
- Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women With Estrogen Receptor–Rich Stage 2 to 3 Breast Cancer: Clinical and Biomarker Outcomes and Predictive Value of the Baseline PAM50-Based Intrinsic Subtype—ACOSOG Z1031
- (2011) Matthew J. Ellis et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
- (2011) M. Dowsett et al. JNCI-Journal of the National Cancer Institute
- Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancer
- (2010) A. DeCensi et al. ANNALS OF ONCOLOGY
- Neoadjuvant endocrine therapy in primary breast cancer: indications and use as a research tool
- (2010) Y H Chia et al. BRITISH JOURNAL OF CANCER
- Using next-generation sequencing for high resolution multiplex analysis of copy number variation from nanogram quantities of DNA from formalin-fixed paraffin-embedded specimens
- (2010) Henry M. Wood et al. NUCLEIC ACIDS RESEARCH
- Neoadjuvant endocrine treatment in primary breast cancer – Review of literature
- (2009) J. Mathew et al. BREAST
- Increase in response rate by prolonged treatment with neoadjuvant letrozole
- (2008) J. Michael Dixon et al. BREAST CANCER RESEARCH AND TREATMENT
- Outcome Prediction for Estrogen Receptor-Positive Breast Cancer Based on Postneoadjuvant Endocrine Therapy Tumor Characteristics
- (2008) M. J. Ellis et al. JNCI-Journal of the National Cancer Institute
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now